Cargando…
Endothelin Receptor A Blockade Is an Ineffective Treatment for Adriamycin Nephropathy
Endothelin is a vasoconstricting peptide that plays a key role in vascular homeostasis, exerting its biologic effects via two receptors, the endothelin receptor A (ETA) and endothelin receptor B (ETB). Activation of ETA and ETB has opposing actions, in which hyperactive ETA is generally vasoconstric...
Autores principales: | Tan, Roderick J., Zhou, Lili, Zhou, Dong, Lin, Lin, Liu, Youhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825716/ https://www.ncbi.nlm.nih.gov/pubmed/24265790 http://dx.doi.org/10.1371/journal.pone.0079963 |
Ejemplares similares
-
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury
por: Zhou, Dong, et al.
Publicado: (2013) -
Targeting the Endothelin A Receptor in IgA Nephropathy
por: Kohan, Donald E., et al.
Publicado: (2023) -
Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018) -
Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton
por: Yin, Lei, et al.
Publicado: (2017) -
Endothelin Blockade in Diabetic Kidney Disease
por: Anguiano, Lidia, et al.
Publicado: (2015)